4//SEC Filing
HAUMANN BRETT K 4
Accession 0001179110-19-012013
CIK 0001583107other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 6:20 PM ET
Size
4.4 KB
Accession
0001179110-19-012013
Insider Transaction Report
Form 4
HAUMANN BRETT K
SVP, Clinical Development
Transactions
- Tax Payment
Ordinary Shares
2019-11-20$17.60/sh−2,692$47,379→ 231,276 total
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001607733
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 6:20 PM ET
- Size
- 4.4 KB